This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, J. P.
Right arrow Articles by Black, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, J. P.
Right arrow Articles by Black, B. L.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2004, p. 3757-3768, Vol. 24, No. 9
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.9.3757-3768.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

HRC Is a Direct Transcriptional Target of MEF2 during Cardiac, Skeletal, and Arterial Smooth Muscle Development In Vivo

Joshua P. Anderson,1 Evdokia Dodou,1 Analeah B. Heidt,1 Sarah J. De Val,1 Eric J. Jaehnig,1 Stephanie B. Greene,1 Eric N. Olson,2 and Brian L. Black1,3*

Cardiovascular Research Institute,1 Department of Biochemistry and Biophysics, University of California, San Francisco, California 94143-0130,3 Department of Molecular Biology, The University of Texas Southwestern Medical Center, Dallas, Texas 75235-91482

Received 29 September 2003/ Returned for modification 24 November 2003/ Accepted 2 February 2004

The HRC gene encodes the histidine-rich calcium-binding protein, which is found in the lumen of the junctional sarcoplasmic reticulum (SR) of cardiac and skeletal muscle and within calciosomes of arterial smooth muscle. The expression of HRC in cardiac, skeletal, and smooth muscle raises the possibility of a common transcriptional mechanism governing its expression in all three muscle cell types. In this study, we identified a transcriptional enhancer from the HRC gene that is sufficient to direct the expression of lacZ in the expression pattern of endogenous HRC in transgenic mice. The HRC enhancer contains a small, highly conserved sequence that is required for expression in all three muscle lineages. Within this conserved region is a consensus site for myocyte enhancer factor 2 (MEF2) proteins that we show is bound efficiently by MEF2 and is required for transgene expression in all three muscle lineages in vivo. Furthermore, the entire HRC enhancer sequence lacks any discernible CArG motifs, the binding site for serum response factor (SRF), and we show that the enhancer is not activated by SRF. Thus, these studies identify the HRC enhancer as the first MEF2-dependent, CArG-independent transcriptional target in smooth muscle and represent the first analysis of the transcriptional regulation of an SR gene in vivo.

* Corresponding author. Mailing address: Cardiovascular Research Institute, 505 Parnassus Ave., Box 0130, San Francisco, CA 94143. Phone: (415) 502-7628. Fax: (415) 514-2550. E-mail: bblack{at}itsa.ucsf.edu.

Molecular and Cellular Biology, May 2004, p. 3757-3768, Vol. 24, No. 9
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.9.3757-3768.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Gordon, J. W., Pagiatakis, C., Salma, J., Du, M., Andreucci, J. J., Zhao, J., Hou, G., Perry, R. L., Dan, Q., Courtman, D., Bendeck, M. P., McDermott, J. C. (2009). Protein Kinase A-regulated Assembly of a MEF2{middle dot}HDAC4 Repressor Complex Controls c-Jun Expression in Vascular Smooth Muscle Cells. J. Biol. Chem. 284: 19027-19042 [Abstract] [Full Text]  
  • Sayers, R. L., Sundberg-Smith, L. J., Rojas, M., Hayasaka, H., Parsons, J. T., Mack, C. P., Taylor, J. M. (2008). FRNK Expression Promotes Smooth Muscle Cell Maturation During Vascular Development and After Vascular Injury. Arterioscler. Thromb. Vasc. Bio. 28: 2115-2122 [Abstract] [Full Text]  
  • Du, M., Perry, R. L. S., Nowacki, N. B., Gordon, J. W., Salma, J., Zhao, J., Aziz, A., Chan, J., Siu, K. W. M., McDermott, J. C. (2008). Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2D. Mol. Cell. Biol. 28: 2952-2970 [Abstract] [Full Text]  
  • Long, X., Creemers, E. E., Wang, D.-Z., Olson, E. N., Miano, J. M. (2007). Myocardin is a bifunctional switch for smooth versus skeletal muscle differentiation. Proc. Natl. Acad. Sci. USA 104: 16570-16575 [Abstract] [Full Text]  
  • Alfieri, C. M., Evans-Anderson, H. J., Yutzey, K. E. (2007). Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle. Am. J. Physiol. Cell Physiol. 292: C1887-C1894 [Abstract] [Full Text]  
  • Jaehnig, E. J., Heidt, A. B., Greene, S. B., Cornelissen, I., Black, B. L. (2006). Increased Susceptibility to Isoproterenol-Induced Cardiac Hypertrophy and Impaired Weight Gain in Mice Lacking the Histidine-Rich Calcium-Binding Protein. Mol. Cell. Biol. 26: 9315-9326 [Abstract] [Full Text]  
  • Pasquet, S., Naye, F., Faucheux, C., Bronchain, O., Chesneau, A., Thiebaud, P., Theze, N. (2006). Transcription Enhancer Factor-1-dependent Expression of the {alpha}-Tropomyosin Gene in the Three Muscle Cell Types. J. Biol. Chem. 281: 34406-34420 [Abstract] [Full Text]  
  • Creemers, E. E., Sutherland, L. B., McAnally, J., Richardson, J. A., Olson, E. N. (2006). Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Development 133: 4245-4256 [Abstract] [Full Text]  
  • Nakagawa, O., Arnold, M., Nakagawa, M., Hamada, H., Shelton, J. M., Kusano, H., Harris, T. M., Childs, G., Campbell, K. P., Richardson, J. A., Nishino, I., Olson, E. N. (2005). Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. Genes Dev. 19: 2066-2077 [Abstract] [Full Text]  
  • Rojas, A., De Val, S., Heidt, A. B., Xu, S.-M., Bristow, J., Black, B. L. (2005). Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. Development 132: 3405-3417 [Abstract] [Full Text]  
  • Loots, G. G., Ovcharenko, I. (2005). Dcode.org anthology of comparative genomic tools. Nucleic Acids Res 33: W56-W64 [Abstract] [Full Text]  
  • Phan, D., Rasmussen, T. L., Nakagawa, O., McAnally, J., Gottlieb, P. D., Tucker, P. W., Richardson, J. A., Bassel-Duby, R., Olson, E. N. (2005). BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart. Development 132: 2669-2678 [Abstract] [Full Text]  
  • Parmacek, M. S. (2004). Myocardin--Not Quite MyoD. Arterioscler. Thromb. Vasc. Bio. 24: 1535-1537 [Full Text]  
  • Dodou, E., Verzi, M. P., Anderson, J. P., Xu, S.-M., Black, B. L. (2004). Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 131: 3931-3942 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»